Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma
Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma
Not yet recruiting · NCT06580223 · Registry updated 2025-07-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma | Blood Protein Disorders, Embolism and Thrombosis, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Thromboembolism, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease, venous thromboembolism | Not yet recruiting | Phase 3 | 2025-07-18 | NCT06580223 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 319 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 2 |